MgShell S.r.l.

MgShell S.r.l. is a healthcare company focused on ophthalmology, specifically targeting retinal diseases with its innovative magnesium-based drug delivery platform. The company aims to enhance patient care by improving treatment effectiveness and adherence while reducing healthcare costs. MgShell's mission is to drive healthcare innovation and reshape the ophthalmological landscape with more effective and patient-friendly treatments. Originating from an academic project, MgShell has evolved into a startup backed by a leadership team with expertise in bioengineering, management, and ophthalmology. The company maintains strong research ties with institutions like Politecnico di Milano. Their core product utilizes magnesium to deliver drugs more effectively within the eye, potentially reducing the frequency and invasiveness of treatments. Ongoing clinical trials support the therapeutic potential of this approach. MgShell targets patients with retinal diseases, healthcare providers in ophthalmology, and pharmaceutical companies interested in advanced drug delivery systems. Their technology aims to improve treatment outcomes for patients and lower costs for healthcare systems.

• Employees 9
• Founded 2019
• Total Funding $535935